Stage III Breast Cancer Completed Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00148681Preoperative Herceptin and Navelbine for Breast CancerTreatment